Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia

References

• Charters EK, Bogaardt H, Freeman‐Sanderson AL, et al. Systematic review and meta-analysis of the impact of dosimetry to dysphagia and aspiration related structures. Head Neck. 2019;41(6):1984–1998.
   PubMed Web of Science ®Google Scholar
• Brodin NP, Kabarriti R, Garg MK, et al. Systematic review of normal tissue complication models relevant to standard fractionation radiation therapy of the head and neck region published after the QUANTEC reports. Int J Radiat Oncol Biol Phys. 2018;100(2):391–407.
   PubMed Web of Science ®Google Scholar
• Duprez F, Madani I, De Potter B, et al. Systematic review of dose-volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer. Dysphagia. 2013;28(3):337–349.
   PubMed Web of Science ®Google Scholar
• Kanayama N, Kierkels RGJ, van der Schaaf A, et al. External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6 months after definitive radiotherapy for head and neck cancer. Radiother Oncol. 2018;129(2):403–408.
   PubMed Web of Science ®Google Scholar
• Sharabiani M, Clementel E, Andratschke N, et al. Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria. Radiother Oncol. 2020;146:143–150.
   PubMed Web of Science ®Google Scholar
• Rosenstein BS. Radiogenomics: identification of genomic predictors for radiation toxicity. Semin Radiat Oncol. 2017;27(4):300–309.
   PubMed Web of Science ®Google Scholar
• Kerns SL, Ostrer H, Rosenstein BS. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov. 2014;4(2):155–165.
   PubMed Web of Science ®Google Scholar
• Ikebe T, Seki K, Nakamura S, et al. Severity of oral mucositis correlates with the response of oral cancer to preoperative radiochemotherapy. Int J Oral Maxillofac Surg. 2005;34(6):642–645.
   PubMed Web of Science ®Google Scholar
• Eade T, Choudhury A, Pollack A, et al. Acute epithelial toxicity is prognostic for improved prostate cancer response to radiation therapy: a retrospective, multicenter, cohort study. Int J Radiat Oncol Biol Phys. 2018;101(4):957–963.
   PubMed Web of Science ®Google Scholar
• Martin D, Rödel F, von der Grün J, et al. Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma. Radiother Oncol. 2020;149:168–173.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou W, Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science. 1997;276(5316):1268–1272.
   PubMed Web of Science ®Google Scholar
• Ghazali N, Shaw RJ, Rogers SN, et al. Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review. Oral Oncol. 2012;48(11):1090–1100.
   PubMed Web of Science ®Google Scholar
• Lyons AJ, West CM, Risk JM, et al. Osteoradionecrosis in head-and-neck cancer has a distinct genotype-dependent cause. Int J Radiat Oncol Biol Phys. 2012;82(4):1479–1484.
   PubMed Web of Science ®Google Scholar
• Werbrouck J, De Ruyck K, Duprez F, et al. Acute normal tissue reactions in head-and-Neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys. 2009;73(4):1187–1195.
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Kim HM, Feng FY, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys. 2011;81(3):e93–e9.
   PubMed Web of Science ®Google Scholar
• Linge A, Lohaus F, Löck S, et al. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol. 2016;121(3):364–373.
   PubMed Web of Science ®Google Scholar
• Löck S, Perrin R, Seidlitz A, et al. Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging. Radiother Oncol. 2017;124(3):533–540.
   PubMed Web of Science ®Google Scholar
• Zips D, Zöphel K, Abolmaali N, et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol. 2012;105(1):21–28.
   PubMed Web of Science ®Google Scholar
• Linge A, Löck S, Gudziol V, et al. Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG. Clin Cancer Res. 2016;22(11):2639–2649.
   PubMed Web of Science ®Google Scholar
• Linge A, Löck S, Krenn C, et al. Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy. Clin Transl Radiat Oncol. 2016;1:19–26.
   PubMedGoogle Scholar
• Schmidt S, Linge A, Zwanenburg A, et al. Development and validation of a gene signature for patients with head and neck carcinomas treated by postoperative radio(chemo)therapy. Clin Cancer Res. 2018;24(6):1364–1374.
   PubMed Web of Science ®Google Scholar
• Brouwer CL, Steenbakkers RJHM, Bourhis J, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines. Radiother Oncol. 2015;117(1):83–90.
   PubMed Web of Science ®Google Scholar
• Deist TM, Dankers FJWM, Valdes G, et al. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: an empirical comparison of classifiers. Med Phys. 2018;45(7):3449–3459.
   PubMed Web of Science ®Google Scholar
• Yahya N, Ebert MA, Bulsara M, et al. Statistical-learning strategies generate only modestly performing predictive models for urinary symptoms following external beam radiotherapy of the prostate: a comparison of conventional and machine-learning methods. Med Phys. 2016;43(5):2040–2052.
   PubMed Web of Science ®Google Scholar
• Budach V, Tinhofer I. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol. 2019;20(6):e313–e26.
   PubMed Web of Science ®Google Scholar
• Tonella L, Giannoccaro M, Alfieri S, et al. Gene expression signatures for head and neck cancer patient stratification: are results ready for clinical application? Curr Treat Options Oncol. 2017;18(5):32.
   PubMed Web of Science ®Google Scholar
• Wang C, Sturgis EM, Chen X, et al. A functional variant at miRNA-122 binding site in IL-1α 3′ UTR predicts risk of recurrence in patients with oropharyngeal cancer. Oncotarget. 2016;7(23):34472–34479.
   PubMedGoogle Scholar
• She Y, Kong X, Ge Y, et al. Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma. Cancer Cell Int. 2020;20(1):22.
   Web of Science ®Google Scholar
• Shackleton M. Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol. 2010;20(2):85–92.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick DT, Liaw H, Lee D, et al. DNA-PK-Dependent RPA2 hyperphosphorylation facilitates DNA repair and suppresses sister chromatid exchange. PLOS One. 2011;6(6):e21424.
   PubMed Web of Science ®Google Scholar
• Dueva R, Iliakis G. Replication protein A: a multifunctional protein with roles in DNA replication, repair and beyond. NAR Cancer. 2020;2(3):zcaa022.
   PubMedGoogle Scholar
• Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 2003;300(5625):1542–1548.
   PubMed Web of Science ®Google Scholar
• Chin W-C, Park Y-J, Koh J, et al. Identification of regulatory factors for mesenchymal stem Cell-Derived salivary epithelial cells in a Co-Culture system. PLOS One. 2014;9(11):e112158.
   PubMed Web of Science ®Google Scholar
• Mona M, Miller R, Li H, et al. MIST1, an inductive signal for salivary amylase in mesenchymal stem cells. IJMS. 2019;20(3):767.
   Web of Science ®Google Scholar
• Andrysik Z, Kim J, Tan AC, et al. A genetic screen identifies TCF3/E2A and TRIAP1 as Pathway-Specific regulators of the cellular response to p53 activation. Cell Rep. 2013;3(5):1346–1354.
   PubMed Web of Science ®Google Scholar
• Miao Q, Ku AT, Nishino Y, et al. Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2. Nat Commun. 2014;5:4088.
   PubMed Web of Science ®Google Scholar
• Yi F, Pereira L, Merrill BJ. Tcf3 functions as a steady-state limiter of transcriptional programs of mouse embryonic stem cell self-renewal. Stem Cells. 2008;26(8):1951–1960.
   PubMed Web of Science ®Google Scholar
• Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-Activated protein kinases. Microbiol Mol Biol Rev. 2011;75(1):50–83.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Moiseenko V, Marks L, et al. Radiotherapy dose–volume effects on salivary gland function. Int J Radiation Oncol Biol Phys. 2010;76(3):S58–S63.
   PubMed Web of Science ®Google Scholar
• Owosho AA, Thor M, Oh JH, et al. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: temporal patterns, risk factors, and testing the QUANTEC guidelines. J Cranio-Maxillofacial Surg. 2017;45(4):595–600.
   PubMed Web of Science ®Google Scholar
• Beetz I, Schilstra C, Visink A, et al. Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night. Radiother Oncol. 2013;109(2):311–316.
   PubMed Web of Science ®Google Scholar
• Kaae JK, Johnsen L, Hansen CR, et al. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy. Acta Oncol. 2019;58(10):1366–1372.
   PubMed Web of Science ®Google Scholar
• Cao J, Zhang X, Jiang B, et al. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiother Oncol. 2021;160:32–39.
   PubMed Web of Science ®Google Scholar
• Pauloski BR, Rademaker AW, Logemann JA, et al. Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer. Head Neck. 2015;37(11):1575–1582.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of Long-Term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(5):1356–1365.
   PubMed Web of Science ®Google Scholar